Santhera Pharmaceuticals Holding AG (SPHDF)

SPHDF Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	191	185	107	81	61	61
Market Cap Growth	72.13%	72.13%	31.69%	33.01%	0.46%	-53.15%
Enterprise Value	191	196	155	112	100	109
Last Close Price	14.75	9.42	11.70	14.10	14.10	31.40
PE Ratio	-	-	1.65	-	-	-
PS Ratio	4.43	4.28	0.87	10.08	-35.00	3.59
PB Ratio	6.25	6.04	1.51	-1.72	42.04	-8.49
P/FCF Ratio	-	-	1.91	-	-	-
P/OCF Ratio	-	-	1.91	-	-	-
EV/Sales Ratio	3.95	4.53	1.26	13.82	-	6.41
EV/EBITDA Ratio	-	-	2.42	-	-	-
EV/EBIT Ratio	-	-	2.54	-	-	-
EV/FCF Ratio	-4.84	-	2.76	-	-	-
Debt / Equity Ratio	1.47	1.47	0.36	-1.02	32.36	-11.20
Debt / EBITDA Ratio	-	-	0.40	-	-	-
Debt / FCF Ratio	-	-	0.46	-	-	-
Asset Turnover	0.30	0.30	1.19	0.10	-	0.15
Inventory Turnover	1.61	1.61	3.37	13.40	8.29	2.84
Quick Ratio	1.19	1.19	0.71	0.05	0.71	0.58
Current Ratio	1.64	1.64	0.76	0.06	0.75	0.61
Return on Equity (ROE)	-95.79%	-95.79%	673.95%	-	-	-908.60%
Return on Assets (ROA)	-15.81%	-15.81%	36.89%	-36.95%	-39.55%	-32.56%
Return on Capital (ROIC)	-27.66%	-27.66%	77.76%	-126.97%	-65.17%	-45.42%
Return on Capital Employed (ROCE)	-	-	80.10%	-	-	-
Earnings Yield	-24.24%	-25.09%	60.65%	-94.37%	-99.47%	-125.46%
FCF Yield	-20.61%	-21.32%	52.24%	-39.69%	-66.92%	-80.73%
Buyback Yield / Dilution	-4.24%	-4.24%	-79.29%	-78.31%	-156.61%	-21.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.